12 August 2024
Louise Strand appointed new CEO of Grevieåsen AB
Grevieåsen AB, the group that includes companies such as Willab, Bole, and Eclipse Biofarmab, has appointed Louise Strand as its new Chief Executive Officer. Louise assumed her new role on 19 October, succeeding Jacob Atthage, who chose to leave the company.
Most recently, Louise served as Business Area Manager for Evidensia Denmark and was a member of the management team of Evidensia Sweden. Prior to that, she held positions including Clinic Manager at Ugglarps Hästklinik, Regional Manager at Woody Bygghandel and Bolist, and Store Manager at Jula. Louise began her career as a sales representative at IKEA.
With more than 20 years of experience in leadership and business management, Louise brings extensive expertise to Grevieåsen’s continued growth and development. In her role, she will focus on creating new business opportunities through the continued development of proprietary brands and by improving the efficiency of existing processes and business models.
“I am very proud to have the opportunity to lead Grevieåsen forward and look forward to getting to know the people within the organisation. Contributing to the creation of sustainable, long-term value and growth is something I feel highly motivated by,” says Louise Strand.
For further information, please contact
Per Gullstrand
CEO, Bjäre Invest AB
per.gullstrand@bjareinvest.se
+46 (0)70 458 24 02
About Grevieåsen AB
Founded in 1972 and located on the Bjäre Peninsula in southern Sweden, Grevieåsen is a group of companies operating within agriculture and equestrian sports. Through businesses such as Willab AB, Bole Sweden, Bole Norway, and Eclipse Biofarmab, the Group has established a strong position within these sectors.
Grevieåsen is part of Bjäre Invest AB, a business group characterised by entrepreneurship and a long-term focus on creating sustainable and enduring value.
